» Articles » PMID: 24467486

FOXO3A Regulation by MiRNA-29a Controls Chondrogenic Differentiation of Mesenchymal Stem Cells and Cartilage Formation

Overview
Journal Stem Cells Dev
Date 2014 Jan 29
PMID 24467486
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Skeletal development and cartilage formation require stringent regulation of gene expression for mesenchymal stem cells (MSCs) to progress through stages of differentiation. Since microRNAs (miRNAs) regulate biological processes, the objective of the present study was to identify novel miRNAs involved in the modulation of chondrogenesis. We performed miRNA profiling and identify miR-29a as being one of the most down-regulated miRNAs during the chondrogenesis. Using chromatin immunoprecipitation, we showed that SOX9 down-regulates its transcription. Moreover, the over-expression of miR-29a strongly inhibited the expression of chondrocyte-specific markers during in vitro chondrogenic differentiation of MSCs. We identified FOXO3A as a direct target of miR-29a and showed a down- and up-regulation of FOXO3a protein levels after transfection of, respectively, premiR- and antagomiR-29a oligonucleotides. Finally, we showed that using the siRNA or premiR approach, chondrogenic differentiation was inhibited to a similar extent. Together, we demonstrate that the down-regulation of miR-29a, concomitantly with FOXO3A up-regulation, is essential for the differentiation of MSCs into chondrocytes and in vivo cartilage/bone formation. The delivery of miRNAs that modulate MSC chondrogenesis may be applicable for cartilage regeneration and deserves further investigation.

Citing Articles

Targeting miR-29 mitigates skeletal senescence and bolsters therapeutic potential of mesenchymal stromal cells.

Ding Z, Ma G, Zhou B, Cheng S, Tang W, Han Y Cell Rep Med. 2024; 5(8):101665.

PMID: 39168101 PMC: 11384963. DOI: 10.1016/j.xcrm.2024.101665.


Women's contribution to stem cell research for osteoarthritis: an opinion paper.

Velot E, Balmayor E, Bertoni L, Chubinskaya S, Cicuttini F, de Girolamo L Front Cell Dev Biol. 2024; 11:1209047.

PMID: 38174070 PMC: 10762903. DOI: 10.3389/fcell.2023.1209047.


Unveiling Mesenchymal Stem Cells' Regenerative Potential in Clinical Applications: Insights in miRNA and lncRNA Implications.

Jankowski M, Farzaneh M, Ghaedrahmati F, Shirvaliloo M, Moalemnia A, Kulus M Cells. 2023; 12(21).

PMID: 37947637 PMC: 10649218. DOI: 10.3390/cells12212559.


Novel Haplotype in the Gene Promoter Associated with Body Length in Pigs.

Luo Y, Xu Q, Xue M, Wang Y, Yang X, Chan S Genes (Basel). 2023; 14(2).

PMID: 36833438 PMC: 9956144. DOI: 10.3390/genes14020511.


Wedelolactone Promotes the Chondrogenic Differentiation of Mesenchymal Stem Cells by Suppressing EZH2.

Qin W, Yang L, Chen X, Ye S, Liu A, Chen D Int J Stem Cells. 2022; 16(3):326-341.

PMID: 36310024 PMC: 10465333. DOI: 10.15283/ijsc22046.